The current prices are delayed, login to your account for live prices
Login
Logo

Eris Lifesciences Share Price

ERIS
₹ 1,384.40
-₹20.20 (-1.44%)
1D
Last updated 15 Jun, 2026, 15:59 IST
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
₹1,380.30
1.44% down today
₹1,409.80
1D LOW
1D HIGH
Open
₹1,408.70
High
₹1,409.80
Low
₹1,380.30
Prev. close
₹1,404.60
Circuit
L
H
₹1,123.70
₹1,685.50
52-week
L
H
₹1,200.00
₹1,910.00

Eris Lifesciences Shareholder Returns

Eris Lifesciences Share Price History

Mkt Cap Cr
19,439.60
P/E
30.02
P/B
4.98
ROE
15.87%
D/E
0.66
ROCE
13.27%
Div. Yield
—
EPS(TTM)
17.86
Turnover
—
EV/EBITDA
19.59
Net Margin
0.00%
Op. Margin
0.00%
ROA
8.79%
Quick Ratio
0.00
Curr. Ratio
2.36
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
ERIS Lifescience outperforming all market indices
Step 1 of 5
Valuation
Overvalued
ERIS Lifescience appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
ERIS Lifescience revenue, operating profit and net profit are growing

Eris Lifesciences Financials

Full statement
Consolidated - Yearly
All values are in INR Crore
Consolidated
Annually
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
1384.4
87
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 87
Buy orders: 0%
Sell orders: 100%
Bearish
3
Neutral
3
Bullish
2
Slightly Bearish
Indicator
Value
Verdict
RSI (14)
55.99
Neutral
ATR (14)
37.9
Neutral
STOCH(9,6)
90.05
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
19.91
Bullish
UO(9)
47.86
Neutral
ROC(12)
3.17
Bullish
WillR(14)
-9.34
Bearish
Period
Simple value
Exponential vaue
5D
1375.18
1380.4
10D
1374.6
1375.92
20D
1372.32
1372.65
50D
1368.32
1371.65
100D
1369.84
1394.65
About Eris Lifesciences
Eris Lifesciences logo
NSE Symbol
ERIS
BSE Symbol
BSE: 540596
ISIN
INE406M01024
Sector Market Cap
₹ 19,439.6 Cr

Eris Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the manufacture and marketing of pharmaceutical products. The Company has a presence in major therapies like oral anti-diabetes, insulins, cardiovascular, vitamins/minerals and dermatology. Its flagship therapies include oral anti-diabetes, cardiovascular disease (CVD), and vitamins, minerals and nutrients (VMN). Its emerging therapies consist of dermatology, insulins, women’s health, central nervous system (CNS), oncology, and nephrology. Its portfolio of brands includes Glimisave, Eritel, LNBloc, Olmin, Crevast, Atorsave, Gluxit, Renerve, Zomelis, Cosvate, Tayo, Cyblex, Remylin, Tendia, Rabonik, Ginkocer, Psorid, Raricap, Serlift, and Onabet, among others. Its patient care initiatives (PCI) platform provides various healthcare solutions to its patients. The Company has a manufacturing plant located in Guwahati, Assam.As of 15 Jun 2026, Eris Lifesciences share price is ₹1,384.40. The stock opened at ₹1,408.70, compared to its previous close of ₹1,404.60. During today's trading session, Eris Lifesciences share price moved in the range of ₹1,380.30 to ₹1,409.80, with an average price of ₹1,395.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,380.30 and a high of ₹1,409.80. On the performance front, Eris Lifesciences share price has declined by 12.73% over the last six months and is down 22.88% on a year-on-year basis.

The market capitalization of Eris Lifesciences is ₹19,440 Crs, with a P/E ratio of 30.0 and a dividend yield of 0.51%.

FAQs on Eris Lifesciences